Carol Levy, DTM 2022: The use of Control-IQ technology in prior MDI and basal-only insulin users with type 2 diabetes

Press/Media

Period	24 Nov 2022

Media coverage

Title	Carol Levy, DTM 2022: The use of Control-IQ technology in prior MDI and basal-only insulin users with type 2 diabetes
Media name/outlet	Touch ENDOCRINOLOGY
Country/Territory	United Kingdom
Date	24/11/22
URL	https://www.touchendocrinology.com/diabetes/conference-hub/carol-levy-dtm-2022-the-use-of-control-iq-technology-in-prior-mdi-and-basal-only-insulin-users-with-type-2-diabetes/
Persons	Carol Levy